Purpose Life Sciences Creates Strategic Advisory Board, Appoints Jeffrey B. Kindler and Calum MacRae, MD, PhD, to Further Efforts in Revolutionizing Global Clinical Trial Research
Retrieved on:
Tuesday, September 19, 2023
SAB, Mills, PPD, Broad Institute, Central Waqf Council, General Electric, PI, Kindler, Cone Health Women's Hospital, Public, McDonald's, Brigham and Women's Hospital, Policy, Clinical trial, Rudolf Koppitz, Research, MIT, Department of Medicine – University of Pamplona, Genomics, DSM-IV codes, Macdonald, Doctor of Philosophy, Associate, Harvard University, Harvard Medical School, Running, MD, Cardiology, MacRae, BWH, Knowledge, Hospital, Health, PLS, Pfizer, Automation, Disease, Pharmaceutical industry, Medicine
"We created this strategic advisory board to help identify progressive clients that are seeking a reliable and trustworthy partner for accelerating their clinical trials and trial programs.
Key Points:
- "We created this strategic advisory board to help identify progressive clients that are seeking a reliable and trustworthy partner for accelerating their clinical trials and trial programs.
- Jeff has a deep understanding of the challenges facing biopharma companies today with trial inefficiencies and delays and Calum leads cutting-edge approaches to innovate translational research.
- Their tremendous experience and knowledge will help us realize a shared vision to modernize clinical trial research and execution for needed patient communities," said PLS CEO, Ed Mills, PhD.
- With more than three decades of experience, Kindler is a leading expert in the pharmaceutical and other health care sectors.